Knott David M Jr
- SEC CIK
- 0001892770
- Latest filing
- Aug 12, 2026
LGND holding history
Ligand Pharmaceuticals Inc in every 13F filed by Knott David M Jr, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −85,000−100.0% | Sold out | Holders |
| Q2 2024 | 85,000 | $7.16M | 2.9% | −30,000−26.1% | Reduced | Holders |
| Q1 2024 | 115,000 | $8.41M | 3.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 115,000 | $8.21M | 3.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 115,000 | $6.89M | 2.7% | 00.0% | Unchanged | Holders |
| Q2 2023 | 115,000 | $8.29M | 3.5% | 00.0% | Unchanged | Holders |
| Q1 2023 | 115,000 | $8.46M | 3.6% | 00.0% | Unchanged | Holders |
| Q4 2022 | 115,000 | $7.68M | 3.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 115,000 | $9.90M | 4.6% | 00.0% | Unchanged | Holders |
| Q2 2022 | 115,000 | $10.3M | 4.8% | 00.0% | Unchanged | Holders |
| Q1 2022 | 115,000 | $12.9M | 4.4% | +40,000+53.3% | Added | Holders |
| Q4 2021 | 75,000 | $11.6M | 4.4% | – | No prior filing | Holders |